Navigation Links
GlaxoSmithKline and Liberty Property Trust/Synterra Partners Transform the Work Environment with the Opening of Five Crescent Drive
Date:4/5/2013

an itemprop="name">John B. Campbell , LEED AP, AIA, RIBA, Principal-in-Charge of Workplace Strategies at Francis Cauffman. "By creating an open and healthy workplace environment focused on providing the right physical and IT tools with a wide variety of work settings throughout the building, the new workplace has transformed the level of energy, engagement and connectivity across the organization."

Daily service to and from Center City via The Navy Yard Express Shuttle along with plentiful parking and key amenities, such as parks with Wi-Fi access and recreational activities and the soon-to-be-completed Courtyard by Marriott, a flagship property with an upscale bar and restaurant, attract employees to a unique and vibrant setting.

Innovation and sustainability from top to bottom
Whether one starts on the top of the building, which offers a green rooftop, or at the front door apron which features Five Standards (Dazzle), a Mural Arts Program commissioned piece of public art by Virgil Marti , GlaxoSmithKline at The Navy Yard delivers excitement and energy. The five 16' x 7' foot steel and mirror polished stainless steel sculptures resemble looking glasses; their design fitting seamlessly along the GSK facade, which appears as a large transparent ship docked at Five Crescent Drive.

The roof is covered 40% with vegetation and an herb garden provides many benefits including: reducing energy costs by providing natural insulation; absorbing storm water reducing the burden on the public storm water system; offering a beautiful space for events and meetings; and providing additional workspace for employees. High-efficiency, low-flow plumbing fixtures are expected to reduce water use by as much as 50% as compared to a traditional building, which will save an estimated 1.8 million gallons of water per year.

The building's ventilation system provides 30% more fresh air th
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Texas A&M System and GlaxoSmithKline receive U.S. Government approval to establish influenza vaccine facility in Texas
2. Isis Initates Phase 2/3 Study Of ISIS-TTR Rx And Earns $7.5 Million Milestone Payment From GlaxoSmithKline
3. GlaxoSmithKline advances multi-city discussion focused on improving the health of US communities
4. Fred Hutchinson Cancer Research Center Partners With GlaxoSmithKline to Develop Muscular Dystrophy Therapeutics
5. GlaxoSmithKline honors healthcare nonprofits with $40,000 IMPACT Award
6. GlaxoSmithKline Sales Down in Q3 against Good Underlying Momentum in the Business
7. Grant & Eisenhofer Represents Key Whistleblower in Justice Dept.s $1.04 Billion Civil Settlement with GlaxoSmithKline
8. GlaxoSmithKlines (GSK) $3 Billion Whistleblower Settlement Has Paid for One Of Americas Most Expensive Failed Corporate Internal Investigations, Qui Tam Whistleblowers Attorneys Say
9. GlaxoSmithKline Share Their Insight on Understanding DDI With a View to Better Prediction and Control
10. GlaxoSmithKline Employees Embark on Long-Term Volunteer Assignments throughout the World
11. The American Council for Patient Liberty on medical marijuana vending machines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... - India Drug Forecast and Market Analysis ... PharmaPoint: Atopic Dermatitis - India ...
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Drug Delivery Systems -- Focus on End ... STUDY OBJECTIVES A drug ...
(Date:1/15/2014)...  Zafgen, Inc., a leading biopharmaceutical company dedicated to ... today announced initial results from its Phase 2a ... aminopeptidase 2 (MetAP2), in patients with Prader-Willi syndrome ... results showed improvements in body weight, hunger-related behaviors, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4
... Inhibitor-, SOUTH SAN FRANCISCO, Calif., Jan. 7 ... has initiated a phase 1/2 trial,of XL184 in patients ... disease while on a regimen containing erlotinib., XL184 ... RET and,VEGFR receptor tyrosine kinases. In the initial phase ...
... scientists today,report that the genetic variant on chromosome ... of heart attack is also associated with up ... (AAA) and intracranial,aneurysm (IA). This is the first ... condition. The paper, entitled ,The same sequence,variant on ...
Cached Medicine Technology:Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 2Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 3Exelixis Initiates Phase 1/2 Trial of XL184 in Patients With Non-Small Cell Lung Cancer 4Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease 2Not Only Lipids and Inflammation: Insight Into a New Cause of Heart Attack and Other Vascular Disease 3
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
(Date:4/17/2014)... University School of Medicine (BUSM) have discovered that ... an experimental model. The findings, reported in the ... , may lead to more effective treatments for ... of the leading causes of illness and death ... impact by limiting the productivity of workers and ...
(Date:4/17/2014)... has the potential to ward off depression among retirees, ... published online in The Journals of Gerontology, ... In the article " Internet Use and Depression Among ... Analysis ," the authors report that Internet use reduced ... among their study sample. , Late-life depression affects ...
(Date:4/17/2014)... days to find a colored ribbon representing a disease. A ... what color ribbon does one think of with lung cancer?, ... many suffering from the disease, black may be the only ... of lung cancer patients, primarily smokers between the ages of ... the stigma often felt by these patients, the emotional toll ...
(Date:4/17/2014)... world is less than 40 years away from a ... and governments, according to a top scientist at the ... in human history, food production will be limited on ... and energy," said Dr. Fred Davies, senior science advisor ... could become as politically destabilizing by 2050 as energy ...
Breaking Medicine News(10 mins):Health News:Is Parkinson's an autoimmune disease? 2Health News:BUSM researchers find anti-seizure drug may reduce alcohol consumption 2Health News:Internet use may cut retirees' depression 2Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Food shortages could be most critical world issue by mid-century 2
... over age 65, experts note, , THURSDAY, May 13 ... heartbeat known as atrial fibrillation in a certain way, ... forms of dementia, new research finds. , In atrial ... causing blood to pool and increasing the potential of ...
... who need more supplementation, study suggests , THURSDAY, May ... in the United States don,t get enough vitamin D, ... prenatal vitamins that many women take do not always ... researchers from the University of Colorado Denver School of ...
... ... research studies of the jellyfish protein apoaequorin accessible for individuals with debilitating conditions. People ... the research arm of Quincy Bioscience. , ... Madison, WI (Vocus) May 13, 2010 -- Quincy Bioscience announces the launch of ...
... ... RQi enterprise™ registration quality improvement solution allows for pre-registration information to be QA managed ... ... Technologies is proud to announce that Piedmont Healthcare Inc. has selected RQi enterprise™ ( ...
... ... Hearing Loss and Hearing Aids ( http://www.aidright.com ) , ... (PRWEB) May 13, 2010 -- AidRight audiology professionals ... caregiver. Through extensive informational portals and a trusted provider network, their newly relaunched ...
... senior citizen,s health, yet fewer than half of all seniors see ... attention are far less likely to engage in any of the ... medications or getting a cane or walker that might prevent ... Center for Health Policy Research. In the study, ...
Cached Medicine News:Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 2Health News:Treating Common Irregular Heartbeat Might Also Ward Off Alzheimer's 3Health News:Many Pregnant Woman Not Getting Enough Vitamin D 2Health News:Quincy Bioscience Launches HOPETrials.com; Research Studies More Accessible For Participants 2Health News:Kramer Healthcare Technologies' RQi enterprise™ Revenue Cycle Solution Selected by Piedmont Healthcare 2Health News:Caregivers Find Hearing Loss Newly Relaunched Website a Welcome Help 2Health News:Falls and follow-ups: Medical attention following a fall critical to senior health 2
... MRAnywhere stands for Medical Records ... Medical Records (EMR) software that ... from within your office, hospital, ... Web. MRAnywhere offers conversion from ...
SOAPware is an Electronic Health Record for clinics. We provide tools to link to billing systems, hospitals, labs, etc....
... Medical Record Software Interface ... Interface with programs, populates ... custom reports. Accumedics Electronic ... is Microsoft compatible allowing ...
... VersaSuite EHR is designed to improve the ... offers the clinician the ability to capture ... in text, image, audio or video formats. ... provides a familiar contemporary windows interface and ...
Medicine Products: